We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DOGZ:NASDAQDogness (International) Corporation Analysis

Data as of 2026-03-29 - not real-time

$1.38

Latest Price

8/10Risk

Risk Level: High

Executive Summary

DOGZ trades at $1.38, well below its 20‑day SMA of 1.51 and far beneath the 50‑day SMA of 2.64, indicating a prolonged downtrend. The 200‑day SMA sits near 10.31, underscoring the depth of the current weakness. RSI is at 28, technically oversold yet the price continues to slip. MACD shows a bullish histogram despite the overall bearish momentum, hinting at a possible short‑term reversal. Volume is trending lower, supporting the bearish bias. Volatility over the past 30 days exceeds 68%, and the stock has endured a historic max drawdown of roughly 96%, reflecting extreme price swings. The DCF‑derived fair value of $0.33 is less than a quarter of the market price, flagging the stock as overvalued. A price‑to‑book of 0.20 suggests cheapness relative to assets, but the company’s debt‑to‑equity ratio of 15.6 and negative operating margin of ‑50.8% raise solvency concerns. Earnings are negative (trailing EPS –0.38) and there is no dividend, making dividend sustainability a non‑issue. The Fear & Greed index reads 66 (“Greed”), indicating market optimism despite weak fundamentals. Overall, the confluence of technical weakness, high volatility, and deteriorating fundamentals paints a bleak near‑term outlook.
Given the bearish technical setup, high volatility, and substantial debt load, the stock carries a high overall risk rating. Geographic exposure to China adds regulatory and market‑specific uncertainties. Consequently, a short‑term sell recommendation is warranted, with a medium‑term hold for investors awaiting a clear turnaround, and a long‑term sell due to the structural challenges.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below 20‑day and 50‑day SMAs
  • RSI in oversold territory yet momentum remains bearish
  • Decreasing volume amid high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Negative earnings and margins
  • High debt‑to‑equity ratio
  • Potential upside if a turnaround in operating cash flow occurs

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Historical max drawdown of ~96%
  • Unsustainable cash burn and lack of dividend
  • Regulatory and market uncertainty in China

Key Metrics & Analysis

Financial Health

Revenue Growth5.50%
Profit Margin-24.63%
ROE-5.86%
ROA-3.80%
Debt/Equity15.59
P/B Ratio0.2
Op. Cash Flow$567.1K
Free Cash Flow$431.0K

Technical Analysis

TrendBearish
RSI28.1
Support$1.30
Resistance$1.75
MA 20$1.51
MA 50$2.64
MA 200$10.31
MACDBullish
VolumeDecreasing
Fear & Greed Index65.98

Valuation

Fair Value$0.33
GradeOvervalued
TypeValue

Risk Assessment

Beta0.45
Volatility68.88%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.